Karla F S Melo Selected Research

Infertility (Sterility)

7/2003

Clinical, hormonal, behavioral, and genetic characteristics of androgen insensitivity syndrome in a Brazilian cohort: five novel mutations in the androgen receptor gene.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karla F S Melo Research Topics

Disease

3	Androgen-Insensitivity Syndrome (Testicular Feminization) 02/2005 - 07/2003
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019 - 12/2006
2	Virilism (Virilization) 02/2008 - 02/2005
1	Hypertension (High Blood Pressure) 01/2020
1	Hypoglycemia (Reactive Hypoglycemia) 01/2019
1	Congenital adrenal hyperplasia due to 21 hydroxylase deficiency 02/2008
1	Insulin Resistance 12/2006
1	46,XY Disorder of Sex Development (Male Pseudohermaphroditism) 07/2003
1	Infertility (Sterility) 07/2003
1	Gynecomastia 07/2003
1	Leiomyoma (Uterine Fibroids) 06/2002
1	Gonadoblastoma 06/2002
1	Gonadal Dysgenesis (Gonadal Agenesis) 06/2002
1	Hypospadias 06/2002
1	Chronic Kidney Failure (Chronic Renal Failure) 06/2002
1	Testicular Germ Cell Tumor 06/2002
1	Neoplasms (Cancer) 06/2002
1	Disorders of Sex Development (Intersexuality) 06/2002

Drug/Important Bio-Agent (IBA)

4	Androgen Receptors (Androgen Receptor)IBA 02/2008 - 07/2003
2	Insulin (Novolin)FDA Link 01/2019 - 12/2006
1	Blood Glucose (Blood Sugar)IBA 01/2020
1	Short-Acting InsulinIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019
1	Steroid 21-Hydroxylase (21 Hydroxylase)IBA 02/2008
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 07/2003
1	SteroidsIBA 07/2003
1	Testosterone (Sustanon)FDA Link 07/2003
1	GonadotropinsIBA 06/2002

Therapy/Procedure

1	Glycemic Control 01/2019
1	Therapeutics 12/2006